Diagnostic and Predictive Value of CD133‐Positive Circulating Tumor Cells as an Indicator of Pathological High‐Risk Factors for Stage I Non‐Small Cell Lung Cancer
Cancer Medicine · 2025-11 · 14 (21)
DOI: 10.1002/cam4.71303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 29.10.2025. Verfasst von Huandong Huo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, AC133 Antigen, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Hope Run Special Fund of Cancer Foundation of China.
Abstract (Originalsprache)
Background
The noninvasive prediction of pathological high‐risk factors in stage I NSCLC patients before surgery remains an area for further investigation, and circulating stem cancer cells are a potential predictive diagnostic indicator. Identifying these factors preoperatively can guide treatment decisions and may improve outcomes. Here, we aim to explore CD133‐positive circulating tumor cells (CTCs) in stage I patients of NSCLC to predict pathological high‐risk factors of patients, thereby aiding clinical decision‐making.
Methods
A total of 192 Stage I NSCLC patients were finally enrolled and underwent surgical intervention. We assessed the level of CD133‐positive CTCs by employing the telomerase reverse Transcriptase‐Based CTC Detection method. The Least Absolute Shrinkage and Selection Operator method (LASSO) and logistic regression were used to analyze the association between CD133‐positive CTCs with pathological high‐risk factors and construct a diagnostic model.
Results
Among all the enrolled patients, postoperative pathology confirmed that 12 patients had pathological high‐risk factors, while 180 patients had no high‐risk factors. The median count of CD133‐positive CTCs before surgery in patients with high‐risk factors was recorded at 1.58 ± 1.83, significantly higher than 0.767 ± 1.13 observed in the group without high‐risk factors ( p = 0.048). Following feature selection by LASSO regression and multivariate logistic regression, it was determined that CD133‐positive CTCs, CT imaging nodule features, and elevated CEA levels can be combined as diagnostic indicators for pathological high‐risk factors in NSCLC patients. The ROC curve derived from internal bootstrap validation, alongside the calibration and DCA plots, affirmed the model's accuracy and predictive capability. After follow‐up, we found that patients without high‐risk pathological factors showed better PFS ( p = 0.044).
Conclusions
This study indicated that CD133‐positive CTCs were associated with pathological high‐risk factors, and the detection of CD133‐positive CTCs may assist treatment decision‐making for patients of NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking…
ORCID-Profile: Huandong Huo, Wen Zhang
Förderung
- Beijing Hope Run Special Fund of Cancer Foundation of China
Zitieren
APA
Huo, H., Zhang, X., Zhang, Q., Lv, Z., Xie, P., Zhang, K., Zhang, W., & Mao, Y. (2025). Diagnostic and Predictive Value of CD133‐Positive Circulating Tumor Cells as an Indicator of Pathological High‐Risk Factors for Stage I Non‐Small Cell Lung Cancer. Cancer Medicine, 14(21). https://doi.org/10.1002/cam4.71303
Vancouver
Huo H, Zhang X, Zhang Q, Lv Z, Xie P, Zhang K, et al. Diagnostic and Predictive Value of CD133‐Positive Circulating Tumor Cells as an Indicator of Pathological High‐Risk Factors for Stage I Non‐Small Cell Lung Cancer. Cancer Medicine. 2025;14(21). doi:10.1002/cam4.71303
BibTeX
@article{Huo2025,
author = {Huo, Huandong and Zhang, Xiaoli and Zhang, Qi and Lv, Zhuoheng and Xie, Peipei and Zhang, Kaitai and Zhang, Wen and Mao, Yousheng},
title = {Diagnostic and Predictive Value of CD133‐Positive Circulating Tumor Cells as an Indicator of Pathological High‐Risk Factors for Stage I Non‐Small Cell Lung Cancer},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {21},
doi = {10.1002/cam4.71303}
}
EUVIMED